Richard Chaisson
Johns Hopkins University
H-index: 125
North America-United States
Top articles of Richard Chaisson
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India | Vaccine | Kunchok Dorjee Tenzin Namdon Sonam Topgyal Ugen Gyatso Tenzin Tsundue | 2024/4/27 |
Adverse Pregnancy Outcomes Among Human Immunodeficiency Virus (HIV)-infected Women Taking Isoniazid Preventive Therapy During the First Trimester | CLINICAL INFECTIOUS DISEASES | Amita Gupta Michael D Hughes Jorge Leon Cruz Anchalee Avihingsanon Noluthando Mwelase | 2024/3/20 |
Adverse Pregnancy Outcomes Among Women with Human Immunodeficiency Virus Taking Isoniazid Preventive Therapy During the First Trimester | Clinical Infectious Diseases | Amita Gupta Michael D Hughes Jorge Leon Cruz Anchalee Avihingsanon Noluthando Mwelase | 2024/3/15 |
US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy | Clinical Infectious Diseases | Sonya Krishnan Richard E Chaisson | 2024/3/15 |
Facilitators and barriers to adolescent participation in a TB clinical trial | The International Journal of Tuberculosis and Lung Disease | JM Mangan KNC Hedges MM Salerno K Tatum B Bouwkamp | 2024/5/1 |
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis | Clinical Infectious Diseases | Huy X Ngo Ava Y Xu Gustavo E Velásquez Nan Zhang Vincent K Chang | 2024/3/11 |
TB prevalence among pregnant women with HIV in Rio de Janeiro, Brazil | The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease | MA Patel B Durovni N Salazar-Austin SC Cavalcante JE Golub | 2024/5/1 |
Factors associated with tuberculosis preventive treatment incompletion: a retrospective Cohort. | Population Medicine | Maciel Ethel Jose Lapa e Silva João Paulo Cola Thiago Prado Kleydson Alves | 2023/4/26 |
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis | Michael Reid Yvan Jean Patrick Agbassi Nimalan Arinaminpathy Alyssa Bercasio Anurag Bhargava | 2023/9/13 | |
Factors associated with non-completion of TB preventive treatment in Brazil | The International Journal of Tuberculosis and Lung Disease | JP Cola T Nascimento do Prado KBA Alves JR Lapa e Silva A Trajman | 2023/3/1 |
Completion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis | The Lancet Respiratory Medicine | Nicholas Winters Robert Belknap Andrea Benedetti Andrey Borisov Jonathon R Campbell | 2023/3/23 |
High isoniazid exposures when administered with rifapentine once weekly for latent tuberculosis in individuals with human immunodeficiency virus | Antimicrobial agents and chemotherapy | Ryan T Jarrett Yuri van der Heijden Matthew S Shotwell Violet Chihota Mark A Marzinke | 2023/2/16 |
Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis | The Lancet Global Health | Theresa Ryckman Jeff Weiser Makaita Gombe Karin Turner Priyanka Soni | 2023/8/1 |
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349) | Clinical Infectious Diseases | April C Pettit Patrick PJ Phillips Ekaterina Kurbatova Andrew Vernon Payam Nahid | 2023/2/1 |
Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB) | Trials | Akash Malhotra Bareng Aletta Sanny Nonyane Evan Shirey Christiaan Mulder Piotr Hippner | 2023/7/25 |
A Standardized Approach for Collection of Objective Data to Support Outcome Determination for Late-Phase Tuberculosis Clinical Trials | American journal of respiratory and critical care medicine | Ekaterina V Kurbatova Patrick PJ Phillips Susan E Dorman Erin E Sizemore Kia E Bryant | 2023/5/15 |
Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester. | Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America | Amita Gupta Michael D Hughes Jorge Leon Cruz Anchalee Avihingsanon Noluthando Mwelase | 2023/9/28 |
First and second doses of Covishield vaccine provided high level of protection against SARS-CoV-2 infection in highly transmissible settings: results from a prospective cohort … | BMJ global health | Tenzin Tsundue Tenzin Namdon Tenzin Tsewang Sonam Topgyal Tashi Dolma | 2022/5/1 |
Pregnancy in Women with HIV in a Tuberculosis Preventive Therapy Trial | JAIDS Journal of Acquired Immune Deficiency Syndromes | Priya Singh Lawrence H Moulton Grace L Barnes Amita Gupta Reginah Msandiwa | 2022/12/1 |
Tuberculosis screening among ambulatory people living with HIV: a systematic review and individual participant data meta-analysis | Ashar Dhana Yohhei Hamada Andre P Kengne Andrew D Kerkhoff Molebogeng X Rangaka | 2022/4/1 |
Co-Authors
